0001209191-19-050309.txt : 20190920 0001209191-19-050309.hdr.sgml : 20190920 20190920160204 ACCESSION NUMBER: 0001209191-19-050309 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190920 DATE AS OF CHANGE: 20190920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Currie Mark G CENTRAL INDEX KEY: 0001478244 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38787 FILM NUMBER: 191104717 MAIL ADDRESS: STREET 1: C/O CYCLERION THERAPEUTICS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc. CENTRAL INDEX KEY: 0001755237 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831895370 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-04-01 2019-04-03 0 0001755237 Cyclerion Therapeutics, Inc. CYCN 0001478244 Currie Mark G C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 President Employee Stock Option (Right to Buy) 12.24 2019-04-01 4 A 0 37279 0.00 A 2021-02-01 Common Stock 37279 37279 D Employee Stock Option (Right to Buy) 16.21 2019-04-01 4 A 0 17490 0.00 A 2022-02-01 Common Stock 17490 17490 D Employee Stock Option (Right to Buy) 14.40 2019-04-01 4 A 0 27772 0.00 A 2023-02-01 Common Stock 27772 27772 D Employee Stock Option (Right to Buy) 17.20 2019-04-01 4 A 0 2500 0.00 A 2025-03-01 Common Stock 2500 2500 D Employee Stock Option (Right to Buy) 11.28 2019-04-01 4 A 0 50794 0.00 A 2026-03-01 Common Stock 50794 50794 D Employee Stock Option (Right to Buy) 18.47 2019-04-01 4 A 0 113413 0.00 A 2027-02-27 Common Stock 113413 113413 D Employee Stock Option (Right to Buy) 16.02 2019-04-01 4 A 0 140984 0.00 A 2028-02-21 Common Stock 140984 140984 D Employee Stock Option (Right to Buy) 14.21 2019-04-01 4 A 0 514698 0.00 A 2029-01-29 Common Stock 514698 514698 D This report has been amended to correct the exercise price of the stock options that were originally issued by Ironwood Pharmaceuticals, Inc. ("Ironwood") as a result of the spin-off of the Issuer from Ironwood, effective on April 1, 2019 ("the Separation"). This option, granted as an annual performance award, is presently exercisable in full. This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation. This footnote has been amended to reflect the number of unvested options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation. This option to purchase 25,208 shares vests in equal installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,500 shares as of the date hereof. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019. /s/ Larry Miller, Attorney-in-Fact 2019-09-20